On February 18, 2026, the Board approved an increase to the company’s existing authorization to repurchase up to $1.0 billion ...
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation (BSX). Such investors are advised to contact Danielle Peyton ...
Boston Scientific is a global leader in medical devices, excelling in both MedSurg and Cardiovascular segments with consistent, industry-beating growth. Q1 2024 was a record quarter, with 21% YoY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results